| ThisCART19A for B-NHL Relapsed After Auto-CAR T (NCT05691153) | The First Affiliated Hospital of Soochow University | 2022-12-01 |
| Ascending Dose Study of FrontlineODP™ Spray Dried Plasma (NCT05629338) | Velico Medical | 2022-12-01 |
| FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma (NCT05934097) | Fate Therapeutics | 2022-12-01 |
| CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma (NCT05613348) | Zhujiang Hospital | 2022-12-01 |
| D-serine AudRem: R33 Phase (NCT05046353) | New York State Psychiatric Institute | 2022-12-01 |
| The Effect of the Egg Shell Nanoparticles Combined With Titanium Dioxide Nanoparticles (NCT06025084) | Egymedicalpedia | 2022-12-01 |
| Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer (NCT05354375) | The Affiliated Hospital of Xuzhou Medical University | 2022-12-01 |
| Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma (NCT04385173) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-12-01 |
| Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy (NCT05640713) | Henan Cancer Hospital | 2022-12-01 |
| Cool Pre-operative TAP Blocks (NCT04761887) | Daniel Wambold | 2022-12-01 |
| Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor (NCT05644509) | The Affiliated Hospital of Xuzhou Medical University | 2022-12-01 |
| The Effect of Intraoperative Infusion of Dexmedetomidine Versus Low Dose Ketamine (NCT05828199) | Al-Azhar University | 2022-12-01 |
| Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19 (NCT05365321) | Andrei Carvalho Sposito | 2022-12-01 |
| First in Human, Dose Escalation, Dose Expansion Study of AUR105 (NCT05605119) | Aurigene Discovery Technologies Limited | 2022-11-30 |
| Shugan Jieyu Capsule for Insomnia Patients With Depressive Symptoms (NCT05764798) | Nanfang Hospital, Southern Medical University | 2022-11-30 |
| A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors (NCT05741242) | Jaime Leandro Foundation for Therapeutic Cancer Vaccines | 2022-11-30 |
| Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) (NCT05642962) | Memorial Sloan Kettering Cancer Center | 2022-11-30 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（MEETCD8-001） (NCT05707676) | L & L Bio Co., Ltd., Ningbo, China | 2022-11-30 |
| A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus (NCT05596747) | Eli Lilly and Company | 2022-11-30 |
| GCC Agonist Signal in the Small Intestine (NCT05107219) | University of Wisconsin, Madison | 2022-11-30 |
| Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection (NCT05620017) | Bio-Thera Solutions | 2022-11-30 |
| Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy (NCT05858983) | Frontera Therapeutics | 2022-11-30 |
| Switch Maintenance in Pancreatic (NCT05419479) | James Cleary, MD, PhD | 2022-11-30 |
| A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma (NCT05376800) | Boehringer Ingelheim | 2022-11-30 |
| A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors (NCT05538130) | Pfizer | 2022-11-30 |
| A Study of IBI353 (Orismilast) in Chinese Healthy Adults (NCT05490316) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-11-30 |
| A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease (NCT05635409) | Region Skane | 2022-11-30 |
| A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects. (NCT05656274) | Tasly Pharmaceutical Group Co., Ltd | 2022-11-29 |
| Pilot Open Label Use of the Hi-OXSR for the Treatment of Post COVID-19 Cognitive Dysfunction (NCT06379620) | University Health Network, Toronto | 2022-11-29 |
| Rapid Administration Pilot for Infusing Dinutuximab (NCT05421897) | Children's Hospital Los Angeles | 2022-11-29 |
| A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM) (NCT05769660) | BeyondBio Inc. | 2022-11-29 |
| Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors (NCT05698888) | Virtuoso BINco, Inc. | 2022-11-29 |
| Oral AMXT 1501 Dicaprate in Combination With IV DFMO (NCT05500508) | Aminex Therapeutics, Inc. | 2022-11-29 |
| BMS-986253 in Myelodysplastic Syndromes (NCT05148234) | National Cancer Institute (NCI) | 2022-11-29 |
| A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions (NCT05665283) | Xcovery Holdings, Inc. | 2022-11-29 |
| A Phase I Study of GFH312 in Healthy Chinese Subjects (NCT05991362) | Zhejiang Genfleet Therapeutics Co., Ltd. | 2022-11-29 |
| Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands) (NCT05798715) | Genuine Research Center, Egypt | 2022-11-29 |
| Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS (NCT05688280) | Immunophotonics, Inc. | 2022-11-29 |
| Study of ARO-RAGE in Healthy Subjects (NCT05533294) | Arrowhead Pharmaceuticals | 2022-11-29 |
| Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients (NCT05537883) | Wake Forest University Health Sciences | 2022-11-29 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants in Australia (NCT05502549) | Shanghai Zhimeng Biopharma, Inc. | 2022-11-29 |
| AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer (NCT05617755) | Arsenal Biosciences, Inc. | 2022-11-29 |
| A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors (NCT05584670) | Sanofi | 2022-11-29 |
| Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. (NCT05686798) | Henry Ford Health System | 2022-11-29 |
| Accelerated TMS in Psychosis (NCT05567848) | Beth Israel Deaconess Medical Center | 2022-11-29 |
| Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults (NCT05613205) | GlaxoSmithKline | 2022-11-28 |
| Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas (NCT05565417) | Immunitas Therapeutics | 2022-11-28 |
| A Study of Silmitasertib (CX-4945) in Healthy Subject (NCT05817708) | Senhwa Biosciences, Inc. | 2022-11-28 |
| Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients (NCT05596045) | Ascletis Pharmaceuticals Co., Ltd. | 2022-11-28 |
| A Study to Investigate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP441 in Sleep-deprived Healthy Participants (NCT05651152) | Jazz Pharmaceuticals | 2022-11-28 |
| Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85 (NCT05667688) | RBP4 Pty Ltd | 2022-11-28 |
| Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older (NCT05624606) | Sanofi Pasteur, a Sanofi Company | 2022-11-28 |
| Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age (NCT05630859) | GlaxoSmithKline | 2022-11-28 |
| Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS (NCT05457010) | Arcellx, Inc. | 2022-11-28 |
| Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam (NCT05633147) | Cinclus Pharma Holding AB | 2022-11-27 |
| A Study of LN-144 in People With Metastatic Melanoma to the Brain (NCT05640193) | Memorial Sloan Kettering Cancer Center | 2022-11-25 |
| A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours (NCT05644392) | Tianjin Medical University Cancer Institute and Hospital | 2022-11-25 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects (NCT05203367) | BAR Pharmaceuticals s.r.l. | 2022-11-25 |
| Intrathecal Double Checkpoint Inhibition (NCT05598853) | University of Zurich | 2022-11-25 |
| Study of BN301, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies (NCT05611853) | BioNova Pharmaceuticals (Shanghai) LTD. | 2022-11-25 |
| DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours (NCT05582850) | Domain Therapeutics SA | 2022-11-24 |
| A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood (NCT05613777) | Boehringer Ingelheim | 2022-11-24 |
| Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors (NCT06614140) | Seqker Biosciences, Inc. | 2022-11-24 |
| NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia (NCT05693558) | Novadip Biosciences | 2022-11-24 |
| A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma (NCT05644379) | Tianjin Medical University Cancer Institute and Hospital | 2022-11-24 |
| Universal BCMA-targeted LUCAR-B68 Cells in Patients With Relapsed/Refractory Multiple Myeloma (NCT05498545) | Second Affiliated Hospital of Xi'an Jiaotong University | 2022-11-24 |
| First Phase Clinical Trial of Single Agent MBF-362 in Solid Tumors (NCT05940571) | Medibiofarma S.L. | 2022-11-24 |
| Venetoclax in Patients With MDS or AML in Relapse After AHSCT (NCT05226455) | Groupe Francophone des Myelodysplasies | 2022-11-23 |
| A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors (NCT06154343) | GeneQuantum Healthcare (Suzhou) Co., Ltd. | 2022-11-23 |
| Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment (NCT05661461) | Aadi Bioscience, Inc. | 2022-11-23 |
| A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC (NCT05410730) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2022-11-23 |
| Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG (NCT07134725) | Federal University of Minas Gerais | 2022-11-23 |
| First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases (NCT05599945) | Novo Nordisk A/S | 2022-11-23 |
| Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis (NCT05451212) | Cabaletta Bio | 2022-11-23 |
| A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1) (NCT06218511) | National Cancer Institute, Naples | 2022-11-22 |
| Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma (NCT05363111) | City of Hope Medical Center | 2022-11-22 |
| Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations (NCT05544552) | Tyra Biosciences, Inc | 2022-11-22 |
| Safety and Effect of Oral RVX000222 in Subjects With Fabry Disease (NCT03228940) | Resverlogix Corp | 2022-11-22 |
| A Study of LY3526318 in Healthy Male Japanese Participants (NCT05580250) | Eli Lilly and Company | 2022-11-22 |
| Neural Correlates of Lidocaine Analgesia (NCT05501600) | Keith M Vogt | 2022-11-22 |
| Study to Evaluate HZN-457 in Healthy Volunteers (NCT05565768) | Horizon Therapeutics Ireland DAC | 2022-11-22 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects (NCT05642377) | Glaceum | 2022-11-22 |
| Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma (NCT05628883) | H. Lee Moffitt Cancer Center and Research Institute | 2022-11-22 |
| This is a Phase 1 Study in Which Healthy Volunteers and Participants with Chronic HBV Infection Will Receive HT-101 or Placebo and Will Be Assessed for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (NCT06746311) | Suzhou HepaThera Biotech Co., Ltd. | 2022-11-22 |
| A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis (NCT05652335) | Janssen Research & Development, LLC | 2022-11-22 |
| A Phase 1 Study to Evaluate Safety and Tolerability of NoNO-42 in Healthy Adults (NCT05636306) | NoNO Inc. | 2022-11-22 |
| Niclosamide in Pediatric Patients With Relapsed and Refractory AML (NCT05188170) | Stanford University | 2022-11-21 |
| Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease (NCT05548452) | Virginia Commonwealth University | 2022-11-21 |
| A Study of PM1009 (Anti-TIGIT/PVRIG) in Patients With Advanced Tumours (NCT05607563) | Biotheus Inc. | 2022-11-21 |
| Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid Tumours (NCT05638334) | Institut de Recherches Internationales Servier | 2022-11-21 |
| Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors (NCT05278208) | Nationwide Children's Hospital | 2022-11-21 |
| Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants (NCT06708520) | Noucor Health S.A. | 2022-11-21 |
| PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer (NCT05234307) | Dwight Owen | 2022-11-21 |
| Open-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in Healthy Male Subjects (NCT05657834) | Sagimet Biosciences Inc. | 2022-11-21 |
| Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer (NCT05277766) | University Hospital, Ghent | 2022-11-21 |
| Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function (NCT05515458) | Chipscreen Biosciences, Ltd. | 2022-11-20 |
| A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study (NCT05990998) | First Affiliated Hospital of Fujian Medical University | 2022-11-20 |
| A Prospective, Open Label, Dose-escalation, SAD/MAD, Multicenter, 24weeks, Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Pharmacodynamics of Investigational Product (VM-001) in Patients With Graft-versus-host Disease(GvHD) (NCT05276076) | ViGenCell Inc. | 2022-11-20 |
| Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults (NCT05171946) | Iman Almansour | 2022-11-20 |
| Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions (NCT05642845) | Pharmtechnology LLC | 2022-11-19 |